Compare COLL & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLL | WLKP |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.3M | 743.7M |
| IPO Year | 2015 | 2014 |
| Metric | COLL | WLKP |
|---|---|---|
| Price | $24.83 | $21.67 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $44.88 | N/A |
| AVG Volume (30 Days) | ★ 613.1K | 16.7K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 8.70% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | $780,567,000.00 | ★ $1,166,695,000.00 |
| Revenue This Year | $6.73 | $16.25 |
| Revenue Next Year | $1.37 | $5.23 |
| P/E Ratio | $39.01 | ★ $15.30 |
| Revenue Growth | N/A | ★ 2.71 |
| 52 Week Low | $21.43 | $17.75 |
| 52 Week High | $50.79 | $23.88 |
| Indicator | COLL | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 58.37 |
| Support Level | $21.67 | $21.51 |
| Resistance Level | $26.39 | $22.03 |
| Average True Range (ATR) | 0.85 | 0.44 |
| MACD | 0.17 | 0.04 |
| Stochastic Oscillator | 61.74 | 72.22 |
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.